Oncology Clinical Development Expertise

Cancer Clinical Development is Complex, Our Experts Can Help

Veristat has extensive experience supporting >560 oncology clinical development programs and >70 oncology marketing applications in the United States, Europe, and Japan. We help oncology developers navigate the complexities of designing and executing their cancer trials in the most highly competitive and complicated market. Our extensive expertise includes traditional cancer treatments, devices/diagnostics as well as specialized therapies including vaccines, gene therapies, cell therapies, and immuno-therapies. 

Oncology Experience

With cancer being the second* leading cause of death today, it’s no wonder that Veristat’s clients are prioritizing their pipelines to develop life-extending cancer therapies. 

Veristat's teams work on a spectrum of amazing cancer treatments including drugs, vaccines, and diagnostics.

  • Cancer clinical development comprises >35% of the work we do
  • Cancer treatments account for 50% of the marketing applications that our teams have prepared, 
  • In the past 5 years, 10 oncology products were approved for NDAs and jNDAs that we prepared

*Source: http://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm

staff_oncology_experience2
staff_oncology_experience.png

Experience in Solid Tumors & Blood Cancers

From bladder to thyroid cancers Veristat is well-equipped to support your next solid tumor trial. Review the table below to see our full range of experience in this oncology category.

Veristat also has expansive experience in blood cancers. Whether malignant or non-malignant we have you covered. 

Click here to learn more about all of our hematology experience.

Oncology_hematologic_experience
oncology_solid_tumore_experience

Customized Oncology Solutions

Our solutions span the entire clinical development life-cycle - and are offered as a comprehensive, all-inclusive solution or as functional support. We offer strategic guidance for informed decision-making, operational support to mitigate trial risks, the statistical knowledge to prove safety and efficacy, the medical oversight to ensure patient safety, and the regulatory expertise to achieve approval success.

 

Solutions Span Early to Late Phase

 

early_to_late_phase_experience

Learn More with These Resources

Webinar Video Replay
Minimize Disruption of Your Oncology Trial

View the Xtalks oncology webinar replay video to hear our experts share examples and lessons learned during the ...

Case Study
Medical Writing Partnership - IND to NDA

Learn how the Veristat medical writing team partnered with a sponsor and supported their entire rare oncology program from IND to NDA.

Fact Sheet
Oncology Fact Sheet

As the number two cause of death in the US, Cancer, in its many forms, has caused widespread suffering for mothers, fathers, sisters, and brothers. Veristat is ...

Request A Proposal